News

From left, Kerry L. Burnstein, Ph.D., Mai Huynh, Govindi Samaranayake, Rolando Lyles, Clara Troccoli, and Priyamvada Rai, Ph.D.

Sylvester Researchers and Colleagues Identify Novel Therapeutic Target for Incurable Prostate Cancer

A collaborative study by researchers at Sylvester Comprehensive Cancer Center at the University of Miami Miller School of Medicine and colleagues has identified a novel therapeutic target for incurable prostate cancer. The research found a critical role for thioredoxin-1, a protein that protects cells from oxidative stress, in the progression of prostate cancer to the incurable castration-resistant stage.

Read more »

From left, Michael A. Kolber, M.D., Ph.D., Hansel Tookes, M.D., M.P.H., and Daniel J. Feaster, Ph.D.

NIDA Grant Awarded to Researchers to Identify Best Practices to Boost PrEP Adherence

An international collaboration among researchers in Miami, New York, and Montreal aims to determine the best strategies for effectively providing people who inject drugs with pre-exposure prophylaxis (PrEP) to protect them from HIV infection. Their efforts will be backed by an $8 million grant just awarded from the National Institute on Drug Abuse.

Read more »

From left, Zachariah P. Zachariah, M.D., with Governor Rick Scott.

Dr. Zachariah Named to State University System’s Board of Governors

Florida Governor Rick Scott has appointed Zachariah P. Zachariah, M.D., one of the nation’s leading cardiologists and medical director of UHealth Cardiology in Fort Lauderdale, to the State University System’s Board of Governors. With 12 universities and more than 341,000 students, the State University System of Florida is the second-largest public university system in the nation.

Read more »

A patient's T cells are transformed through state-of-the-art genetic engineering into supercharged cancer-hunting cellular therapy.

FDA Approves ‘Living Drug’ for Treatment of Aggressive Blood Cancer

Sylvester Comprehensive Cancer Center is one of a very limited number of sites in the United States that will provide a newly approved innovative treatment for diffuse large B cell lymphoma — an aggressive form of blood cancer. It takes a patient’s own immune cells (T cells), and uses state-of-the-art genetic engineering to transform them into a supercharged cancer-hunting cellular therapy.

Read more »

Patricia Emard.

Breast Cancer Survivor: On the Road Again

With three children and nine grandchildren spread around the country, Patricia Emard, 64, who retired as assistant director of bus operations for Miami-Dade Transit, enjoys traveling and visiting family members. In fact, in the spring of 2015, she was staying with her daughter, Rachelle, in Washington, D.C., when she discovered a lump in her breast during one of her regular self-examinations.

Read more »